HY-108913-1mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
HY-108913-10mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
HY-108913-100mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
HY-108913-25mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
HY-108913-5mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
HY-108913-50mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
HY-108913-1mL
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-D0815-10mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-100mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-5mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-50mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-500mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-N2503-1mg
|
MedChemexpress LLC
|
Ginsenoside F4 [CAS 181225-33-2]
|
|
COVID-19-immunoregulation
|
|
HY-N2503-5mg
|
MedChemexpress LLC
|
Ginsenoside F4 [CAS 181225-33-2]
|
|
COVID-19-immunoregulation
|
|